Non-clinical and clinical evaluation of antiviral medicinal products and monoclonal antibodies for the prevention and treatment of COVID-19 - Scientific guideline

EMEA-001757-PIP02-15-M03

Procedural advice on the accelerated assessment of marketing authorisation applications pursuant to Article 44 (3) of Regulation (EU) No 2019/6

Valproate : PRAC non-interventional imposed PASS final study report assessment report - EMEA/H/N/PSR/J/0043

Valproate : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - EMEA/H/N/PSR/J/0043

Valproate : List of nationally authorised medicinal products - EMEA/H/N/PSR/J/0043

Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorised

Herbal medicinal product: Fumariae herbaArray, F: Assessment finalised

Public-health advice during COVID-19 pandemic

Simplified summary - EMA/ECDC/EFSA fourth joint report on the integrated analysis of the antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA (JIACRA IV)